Potential of renin-angiotensin system inhibition to improve metabolic bone disorders

Mahnaz Momenzadeh ¹ * , Maryam Khosravian ² , Bhaskar VKS Lakkakula ³

Cited by CrossRef: 5

1- Nourmohammadi H, Abdan Z, Amin Hashemipour S, Sarokhani D, Abdan M, Fakhri M, Dehkordi A. Prevalence of Osteoporosis and Osteopenia in People Over 60 Years in Iran. 2022;13(1):11 [Crossref]

2- Garbieri T, Martin V, Santos C, Gomes P, Fernandes M. The Embryonic Chick Femur Organotypic Model as a Tool to Analyze the Angiotensin II Axis on Bone Tissue. Pharmaceuticals. 2021;14(5):469 [Crossref]

3- Valilshchykov M, Babalyan V, Ionov I, Babaieva O. Peculiarities of Reparative Osteogenesis in Fractures of the Proximal Femur in Patients with Concomitant Arterial Hypertension. Biomed Pharmacol J. 2021;14(4):1815 [Crossref]

4- Fan Z, Kitaura H, Ren J, Ohori F, Noguchi T, Marahleh A, Ma J, Kanou K, Miura M, Narita K, Lin A, Mizoguchi I. Azilsartan inhibits inflammation-triggered bone resorption and osteoclastogenesis in vivo via suppression of TNF-α expression in macrophages. Front Endocrinol. 2023;14 [Crossref]

5- Mkhize B, Mosili P, Ngubane P, Sibiya N, Khathi A. The Relationship between Renin–Angiotensin–Aldosterone System (RAAS) Activity, Osteoporosis and Estrogen Deficiency in Type 2 Diabetes. IJMS. 2023;24(15):11963 [Crossref]

6- Liang J, Xu J, Cao Y, Wei Y, Lin G, Jin J, Li C, Lu K. Association between triglyceride‑glucose index and lumbar bone mineral density among Chinese individuals with osteoporotic fractures: a cross sectional study. Sci Rep. 2025;15(1) [Crossref]

7- PAVLOV S, BABALYAN V, VALILSHCHIKOV M, BABENKO N, KUMETCHKO M, LITVINOVA O, SEMKO N. The role of cytokines in the mechanisms of regulation of reparative processes in modeling fractures of the proximal femur secondary to the correction of concomitant arterial hypertension. Minerva Orthop. 2022;73(3) [Crossref]